Beatrice U Mueller
Overview
Explore the profile of Beatrice U Mueller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thienemann F, Ntusi N, Battegay E, Mueller B, Cheetham M
Cardiovasc Diagn Ther
. 2020 May;
10(2):376-385.
PMID: 32420119
New and changing patterns of multimorbidity (MM), i.e., multiple concurrent acute or chronic diseases in a person, are emerging in low- and middle-income countries (LMICs). The interplay of underlying population-specific...
2.
Jeker B, Farag S, Taleghani B, Novak U, Mueller B, Li Q, et al.
Bone Marrow Transplant
. 2020 Mar;
55(10):2047-2051.
PMID: 32214229
No abstract available.
3.
Schnell B, Seipel K, Bacher U, Jeker B, Mueller B, Banz Y, et al.
Hemasphere
. 2019 Nov;
3(2):e180.
PMID: 31723819
Whereas the molecular events underlying acute myeloid leukemia (AML) are increasingly identified, dynamics of hematologic recovery following induction chemotherapy remain mysterious. Platelet recovery may vary between incomplete and excess recovery...
4.
Griessbach A, Mueller B, Battegay E, Beeler P
Drug Alcohol Depend
. 2019 Nov;
205:107708.
PMID: 31715439
Background: The Wetterling alcohol withdrawal syndrome (AWS) scale determines withdrawal severity and guides treatment. We investigated associations between maximum AWS scores and clinical outcomes. Methods: This retrospective cohort study considered...
5.
Roininen S, Cheetham M, Mueller B, Battegay E
Medicine (Baltimore)
. 2019 Sep;
98(37):e17101.
PMID: 31517840
Background: Caregivers encounter serious and substantial challenges in managing hypertension in patients with subclinical or clinical borderline personality disorder (BPD). These challenges include therapeutic conflicts resulting from harmful drug-drug, and...
6.
Fassbind P, Jeker B, Mueller B, Bacher U, Zimmerli S, Endrich O, et al.
Leuk Lymphoma
. 2019 Apr;
60(10):2423-2431.
PMID: 30943056
Induction chemotherapy in AML patients may have life-threatening side effects requiring intensive care unit (ICU) treatment. We analyzed all AML patients receiving intensive chemotherapy at a single academic center between...
7.
Mueller B, Seipel K, Pabst T
Eur J Intern Med
. 2018 Dec;
58:28-32.
PMID: 30527920
Most patients above 60 years with acute myeloid leukemia (AML) will die from their disease. Nevertheless, the treatment concepts in elderly patients with myelodysplastic syndromes (MDS) and AML are rapidly...
8.
Mueller B, Seipel K, Bacher U, Pabst T
Cancers (Basel)
. 2018 Sep;
10(9).
PMID: 30235847
While the majority of patients with acute myeloid leukemia (AML) are above the age of 65 years at diagnosis, the outcome of older AML patients remains disappointing. Even if standard...
9.
Alva L, Bacher U, Seipel K, Taleghani B, Mueller B, Novak U, et al.
Transfusion
. 2018 Sep;
58(10):2365-2373.
PMID: 30203418
Background: Patients with acute myeloid leukemia (AML) undergoing consolidation with autologous stem cell transplantation (ASCT) depend on the successful mobilization of peripheral blood stem cells. However, the factors affecting the...
10.
Farag S, Jeker B, Bacher U, Taleghani B, Mueller B, Novak U, et al.
Hematol Oncol
. 2018 Aug;
36(4):671-678.
PMID: 30110717
Consolidation in myeloma patients with high-dose melphalan chemotherapy (Mel HDCT) and autologous transplantation (ASCT) is standard of care since more than 2 decades. However, definite cure remains exceptional despite intensive...